eli lilly semaglutide drug Ozempic maker slumps further in fight with Lilly, Zepbound Earnings from Eli Lilly, Novo

References: IQVIA LAAD pharmacy claims data, US Market Access Strategy Consulting analysis Eli Lilly Tightens Access to Diabetes Drug, Frustrating Some People with Obesity, STAT News New Demand in an Old Market Read part 2 of this blog series to learn how the launch of Mounjaro transformed the GLP-1 market and led to the emergence of a new type of patient access profile thats challenging todays traditional diabetes care paradigm

Gradually replacing highly processed items with whole-food alternatives allows taste preferences to adapt over time

Shipping is free overnight or two-day delivery with refrigerated packaging

Witteles RM, Keu KV, Quon A, Tavana H, Fowler MB

Your Health, Your Terms Start Feeling Like Yourself Again Get your free practice guide and a $100 voucher toward your first visit